The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Zero-order drug delivery: State of the art and future prospects
Abstract
Pharmaceutical drugs are an important part of the global healthcare system, with some estimates suggesting over 50% of the world's population takes at least one medication per day. Most drugs are delivered as immediate-release formulations that lead to a rapid increase in systemic drug concentration. Although these formulations have historically played an important role, they can be limited by poor patient compliance, adverse side effects, low bioavailability, or undesirable pharmacokinetics. Drug delivery systems featuring first-order release kinetics have been able to improve pharmacokinetics but are not ideal for drugs with short biological half-lives or small therapeutic windows. Zero-order drug delivery systems have the potential to overcome the issues facing immediate-release and first-order systems by releasing drug at a constant rate, thereby maintaining drug concentrations within the therapeutic window for an extended period of time. This release profile can be used to limit adverse side effects, reduce dosing frequency, and potentially improve patient compliance. This review covers strategies being employed to attain zero-order release or alter traditionally first-order release kinetics to achieve more consistent release before discussing opportunities for improving device performance based on emerging materials and fabrication methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Designing hydrogels for controlled drug delivery
Li, J., & Mooney, D. J. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.71 · Cited by 4,832
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816 · cited 1×
“Increasing particle size [60–62], lactic acid copolymer content [63–67], and molecular weight [65,68–71] have generally been shown to slow the rate of drug release, though not necessarily alter the profile from first-order kinetics.”
BackgroundRitger, P. L., & Peppas, N. A. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90034-4 · Cited by 3,830
Hydrogels in drug delivery: Progress and challenges
Hoare, T. R., & Kohane, D. S. (2008) · Polymer · doi:10.1016/j.polymer.2008.01.027 · Cited by 3,776
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Drug Solubility: Importance and Enhancement Techniques
Savjani, K. T., Gajjar, A. K., & Savjani, J. K. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/195727 · Cited by 2,004
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
On the importance and mechanisms of burst release in matrix-controlled drug delivery systems
Huang, X., & Brazel, C. S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00248-6 · Cited by 1,813
Langer, R. (1990) · Science · doi:10.1126/science.2218494 · Cited by 1,778
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Microneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Volume phase transition in a nonionic gel
Hirokawa, Y., & Tanaka, T. (1984) · The Journal of Chemical Physics · doi:10.1063/1.447548 · Cited by 1,604
Insoluble drug delivery strategies: review of recent advances and business prospects
Kalepu, S., & Nekkanti, V. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.003 · Cited by 1,410
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,286
Why degradable polymers undergo surface erosion or bulk erosion
Burkersroda, F. V., Schedl, L., & Göpferich, A. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00170-9 · Cited by 1,146
Advanced materials and processing for drug delivery: The past and the future
Zhang, Y., Chan, H. F., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.003 · Cited by 1,000
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention
Singh, B. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00204-7 · Cited by 946
In situ forming injectable hydrogels for drug delivery and wound repair
Dimatteo, R., Darling, N. J., & Segura, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.007 · Cited by 896
Enzyme-catalysed assembly of DNA hydrogel
Um, S. H., Lee, J. B., Park, N., Kwon, S. Y., Umbach, C. C., & Luo, D. (2006) · Nature Materials · doi:10.1038/nmat1741 · Cited by 869
A controlled-release microchip
Santini, J. T., Cima, M. J., & Langer, R. (1999) · Nature · doi:10.1038/16898 · Cited by 868
McAllister, D. V., Wang, P. M., Davis, S. P., Park, J.-H., Canatella, P. J., Allen, M. G., & Prausnitz, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2331316100 · Cited by 859
Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness Model
Ernst, F. R., & Grizzle, A. J. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31229-3 · Cited by 849
Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals
Homayun, B., Lin, X., & Choi, H.-J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030129 · Cited by 837
Xu, S., Nie, Z., Seo, M., Lewis, P., Kumacheva, E., Stone, H. A., Garstecki, P., Weibel, D. B., Gitlin, I., & Whitesides, G. M. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462226 · Cited by 830
The global flood protection savings provided by coral reefs
Beck, M. W., Losada, I. J., Menéndez, P., Reguero, B. G., Díaz-Simal, P., & Fernández, F. (2018) · Nature Communications · doi:10.1038/s41467-018-04568-z · Cited by 786
Viswanathan, M., Golin, C. E., Jones, C. D., Ashok, M., Blalock, S. J., Wines, R. C. M., Coker-Schwimmer, E. J. L., Rosen, D. L., Sista, P., & Lohr, K. N. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00538 · Cited by 754
Griffith, L. G. (2000) · Acta Materialia · doi:10.1016/s1359-6454(99)00299-2 · Cited by 730
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Valencia, P. M., Farokhzad, O. C., Karnik, R., & Langer, R. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.168 · Cited by 698
Boontheekul, T., Kong, H.-J., & Mooney, D. J. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.044 · Cited by 659
Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 609
Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults
Budnitz, D. S., Shehab, N., Kegler, S. R., & Richards, C. L. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00006 · Cited by 607
Strategies to Modify the Drug Release from Pharmaceutical Systems
(2015) · Elsevier eBooks · doi:10.1016/c2014-0-02342-8 · Cited by 607
Xu, Q., Hashimoto, M., Dang, T. T., Hoare, T., Kohane, D. S., Whitesides, G. M., Langer, R., & Anderson, D. G. (2009) · Small · doi:10.1002/smll.200801855 · Cited by 602
Lack of Pain Associated with Microfabricated Microneedles
Kaushik, S., Hord, A. H., Denson, D. D., McAllister, D. V., Smitra, S., Allen, M. G., & Prausnitz, M. R. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200102000-00041 · Cited by 576
Wen, H., Jung, H., & Li, X. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9814-9 · Cited by 574
Development of fibrin derivatives for controlled release of heparin-binding growth factors
Sakiyama-Elbert, S. E., & Hubbell, J. A. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00221-7 · Cited by 565
Chien, Y. (1991) · CRC Press eBooks · doi:10.1201/9780367805456 · Cited by 561
Mittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
Leong, K. W., Brott, B. C., & Langer, R. (1985) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820190806 · Cited by 541
Mucoadhesive drug delivery system: An overview
Boddupalli, B., Mohammed, Z. K., Nath, R., & Banji, D. (2010) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/0110-5558.76436 · Cited by 537
Hua, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00524 · Cited by 527
Transdermal Delivery of Insulin Using Microneedles in Vivo
Martanto, W., Davis, S. P., Holiday, N. R., Wang, J., Gill, H. S., & Prausnitz, M. R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029282.44140.2e · Cited by 521
Microparticles and nanoparticles for drug delivery
Kohane, D. S. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21301 · Cited by 517
Polymer Microneedles for Controlled-Release Drug Delivery
Park, J.-H., Allen, M. G., & Prausnitz, M. R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0028-9 · Cited by 493
Extracellular Total Electrolyte Concentration Imaging for Electrical Brain Stimulation (EBS)
Sajib, S. Z. K., Lee, M. B., Kim, H. J., Woo, E. J., & Kwon, O. I. (2018) · Scientific Reports · doi:10.1038/s41598-017-18515-3 · Cited by 491
Salt effects on the phase transition of ionic gels
Ohmine, I., & Tanaka, T. (1982) · The Journal of Chemical Physics · doi:10.1063/1.443780 · Cited by 485
Controlled Synthesis of Nonspherical Microparticles Using Microfluidics
Dendukuri, D., Tsoi, K., Hatton, T. A., & Doyle, P. S. (2005) · Langmuir · doi:10.1021/la047368k · Cited by 482
Microneedles: an emerging transdermal drug delivery system
Bariya, S. H., Gohel, M. C., Mehta, T. A., & Sharma, O. P. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01369.x · Cited by 455
Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material
Sundback, C. A., Shyu, J. Y., Wang, Y., Faquin, W. C., Langer, R. S., Vacanti, J. P., & Hadlock, T. A. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.004 · Cited by 443
First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip
Farra, R., Sheppard, N. F., McCabe, L., Neer, R. M., Anderson, J. M., Santini, J. T., Cima, M. J., & Langer, R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003276 · Cited by 437
The vagina as a route for systemic drug delivery
Hussain, A., & Ahsan, F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.034 · Cited by 435
Impact of Dosage Frequency on Patient Compliance
Paes, A. H. P., Bakker, A., & Soe-Agnie, C. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.10.1512 · Cited by 408
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation
Park, K., Skidmore, S., Hadar, J., Garner, J., Park, H., Otte, A., Soh, B. K., Yoon, G., Yu, D., Yun, Y., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.003 · Cited by 404
Issues in long-term protein delivery using biodegradable microparticles
Ye, M., Kim, S., & Park, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.011 · Cited by 386
Matriano, J. A., Cormier, M., Johnson, J., Young, W. A., Buttery, M., Nyam, K., & Daddona, P. E. (2002) · Pharmaceutical Research · doi:10.1023/a:1013607400040 · Cited by 373
Therapeutic applications of implantable drug delivery systems
Dash, A., & Cudworth, G. (1998) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(98)00027-6 · Cited by 358
How porosity and size affect the drug release mechanisms from PLGA-based microparticles
Klose, D., Siepmann, F., Elkharraz, K., Krenzlin, S., & Siepmann, J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.07.031 · Cited by 358
Han, F. Y., Thurecht, K. J., Whittaker, A. K., & Smith, M. T. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00185 · Cited by 358
Erosion kinetics of hydrolytically degradable polymers.
Tamada, J. A., & Langer, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.552 · Cited by 356
Controlling Rigidity and Degradation of Alginate Hydrogels via Molecular Weight Distribution
Kong, H. J., Kaigler, D., Kim, K., & Mooney, D. J. (2004) · Biomacromolecules · doi:10.1021/bm049879r · Cited by 350
Westbrook, J. I., Rob, M. I., Woods, A., & Parry, D. (2011) · BMJ Quality & Safety · doi:10.1136/bmjqs-2011-000089 · Cited by 348
Wang, J., Wang, B. M., & Schwendeman, S. P. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00137-2 · Cited by 343
A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices
Zhang, S., Bellinger, A. M., Glettig, D. L., Barman, R., Lee, Y.-A. L., Zhu, J., Cleveland, C., Montgomery, V. A., Gu, L., Nash, L. D., et al. (2015) · Nature Materials · doi:10.1038/nmat4355 · Cited by 326
Advances in transdermal insulin delivery
Zhang, Y., Yu, J., Kahkoska, A. R., Wang, J., Buse, J. B., & Gu, Z. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.006 · Cited by 325
Resident and “Inflammatory” Dendritic Cells in Human Skin
Zaba, L. C., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.225 · Cited by 319
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems
Alonso, M. J., Gupta, R. K., Min, C., Siber, G. R., & Langer, R. (1994) · Vaccine · doi:10.1016/0264-410x(94)90092-2 · Cited by 313
Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications
Larrañeta, E., Stewart, S., Ervine, M., Al-Kasasbeh, R., & Donnelly, R. (2018) · Journal of Functional Biomaterials · doi:10.3390/jfb9010013 · Cited by 303
Mohamed, F., & van der Walle, C. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21082 · Cited by 299
Swelling-controlled release in hydrogel matrices for oral route
Colombo, P. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90026-z · Cited by 294
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Zhong, H., Chan, G., Hu, Y., Hu, H., & Ouyang, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040263 · Cited by 288
Microfabricated drug delivery systems: from particles to pores
Tao, S. L., & Desai, T. A. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00227-2 · Cited by 286
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
Blanco, M. D., & Alonso, M. J. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00056-8 · Cited by 269
Breaching the skin's barrier to drugs
Barry, B. W. (2004) · Nature Biotechnology · doi:10.1038/nbt0204-165 · Cited by 267
Krohe, M., Eek, D., Mazar, I., Horsfield, A., Pompilus, F., Friebe, R., & Shields, A. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106629 · Cited by 265
Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals
Bellinger, A. M., Jafari, M., Grant, T. M., Zhang, S., Slater, H. C., Wenger, E. A., Mo, S., Lee, Y.-A. L., Mazdiyasni, H., Kogan, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2374 · Cited by 262
Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres
Chen, W., Palazzo, A., Hennink, W. E., & Kok, R. J. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00896 · Cited by 262
Chitosan Microneedle Patches for Sustained Transdermal Delivery of Macromolecules
Chen, M.-C., Ling, M.-H., Lai, K.-Y., & Pramudityo, E. (2012) · Biomacromolecules · doi:10.1021/bm301293d · Cited by 259
Functional Polymeric Microparticles Engineered from Controllable Microfluidic Emulsions
Wang, W., Zhang, M.-J., & Chu, L.-Y. (2014) · Accounts of Chemical Research · doi:10.1021/ar4001263 · Cited by 255
Blanco, D., & Alonso, M. J. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00011-3 · Cited by 251
A Prospective Study of Long-term Intrathecal Morphine in the Management of Chronic Nonmalignant Pain
Anderson, V. C., & Burchiel, K. J. (1999) · Neurosurgery · doi:10.1097/00006123-199902000-00026 · Cited by 236
Cun, D., Jensen, D. K., Maltesen, M. J., Bunker, M., Whiteside, P., Scurr, D., Foged, C., & Nielsen, H. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.008 · Cited by 233
Polymeric microneedles for controlled transdermal drug delivery
Singh, P., Carrier, A., Chen, Y., Lin, S., Wang, J., Cui, S., & Zhang, X. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.022 · Cited by 229
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
Kirtane, A. R., Abouzid, O., Minahan, D., Bensel, T., Hill, A. L., Selinger, C., Bershteyn, A., Craig, M., Mo, S. S., Mazdiyasni, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02294-6 · Cited by 227
(2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374195-0.x0001-8 · Cited by 227
The oral cavity as a site for systemic drug delivery
Rathbone, M. J., Drummond, B. K., & Tucker, I. G. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90024-8 · Cited by 219
The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers
Grossman, S. A., Reinhard, C., Colvin, O. M., Chasin, M., Brundrett, R., Tamargo, R. J., & Brem, H. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.4.0640 · Cited by 217
Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice
(2010) · Wiley eBooks · doi:10.1002/9780470640487 · Cited by 214
Zero-Order Controlled-Release Polymer Matrices for Micro- and Macromolecules
Hsieh, D. S. T., Rhine, W. D., & Langer, R. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600720105 · Cited by 214
Pons-Faudoa, F. P., Ballerini, A., Sakamoto, J., & Grattoni, A. (2019) · Biomedical Microdevices · doi:10.1007/s10544-019-0389-6 · Cited by 210
Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems
Schneider, C., Langer, R., Loveday, D., & Hair, D. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.004 · Cited by 209
Continuous Subcutaneous Insulin Infusion: A Comprehensive Review of Insulin Pump Therapy
Lenhard, M. J., & Reeves, G. D. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.19.2293 · Cited by 205
Overview of Controlled Release Mechanisms
Siegel, R. A., & Rathbone, M. J. (2012) · Fundamentals and Applications of Controlled Release Drug Delivery · doi:10.1007/978-1-4614-0881-9_2 · Cited by 202
Wang, N. X., & von Recum, H. A. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201000206 · Cited by 200
Chung, H. J., Lee, Y., & Park, T. G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.008 · Cited by 194
Wu, J., Kong, T., Yeung, K. W. K., Shum, H. C., Cheung, K. M. C., Wang, L., & To, M. K. T. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.03.022 · Cited by 191
Vallejo-Vaz, A. J., Robertson, M., Catapano, A. L., Watts, G. F., Kastelein, J. J., Packard, C. J., Ford, I., & Ray, K. K. (2017) · Circulation · doi:10.1161/circulationaha.117.027966 · Cited by 185
Implantable microchip: the futuristic controlled drug delivery system
Sutradhar, K. B., & Sumi, C. D. (2016) · Drug Delivery · doi:10.3109/10717544.2014.903579 · Cited by 185
Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects
Wang, Q., Wang, J., Lu, Q., Detamore, M. S., & Berkland, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.052 · Cited by 183
Ishihara, M., Obara, K., Ishizuka, T., Fujita, M., Sato, M., Masuoka, K., Saito, Y., Yura, H., Matsui, T., Hattori, H., et al. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10427 · Cited by 178
Clinical microneedle injection of methyl nicotinate: stratum corneum penetration
Sivamani, R. K., Stoeber, B., Wu, G. C., Zhai, H., Liepmann, D., & Maibach, H. (2005) · Skin Research and Technology · doi:10.1111/j.1600-0846.2005.00107.x · Cited by 171
Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy
Renard, É. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00216-3 · Cited by 170
Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres
Tabata, Y., Gutta, S., & Langer, R. (1993) · Pharmaceutical Research · doi:10.1023/a:1018929531410 · Cited by 167
Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings
Malcolm, R. K., Woolfson, A. D., Toner, C. F., Morrow, R. J., & McCullagh, S. D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki326 · Cited by 166
Micro- and nanofabrication methods in nanotechnological medical and pharmaceutical devices
Betancourt, T., & Brannon-Peppas, L. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.4.483 · Cited by 165
Kang, J., & Schwendeman, S. P. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00101-6 · Cited by 162
Kadam, R. S., Bourne, D. W. A., & Kompella, U. B. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.044925 · Cited by 162
An Overview of Insulin Pumps and Glucose Sensors for the Generalist
McAdams, B., & Rizvi, A. A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5010005 · Cited by 158
Nidhi, N., Rashid, M., Kaur, V., Hallan, S. S., Sharma, S., & Mishra, N. (2014) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2014.10.001 · Cited by 157
Best Practices for Intrathecal Drug Delivery for Pain
Prager, J. P., Deer, T. R., Levy, R. M., Bruel, B. M., Buchser, E., Caraway, D. L., Cousins, M. J., Jacobs, M. S., McGlothlen, G. L., Rauck, R. L., et al. (2014) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12146 · Cited by 156
Lee, B. K., Yun, Y. H., Choi, J. S., Choi, Y. C., Kim, J. D., & Cho, Y. W. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.02.011 · Cited by 152
Cui, F., Cun, D., Tao, A., Yang, M., Shi, K., Zhao, M., & Guan, Y. Q. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.001 · Cited by 151
Martin, F., Walczak, R. J., Boiarski, A. A., Cohen, M. J., West, T., Cosentino, C., & Mauro Ferrari, B. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.024 · Cited by 150
Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide
Woolfson, A. D., Malcolm, K. R., Morrow, R. J., Toner, C. F., & McCullagh, S. D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.026 · Cited by 149
Osmotic Drug Delivery System as a Part of Modified Release Dosage Form
Keraliya, R. A., Patel, C. A., Patel, P., Keraliya, V., Soni, T. G., Patel, R. C., & Patel, M. M. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/528079 · Cited by 149
Best-practice surgical techniques for intrathecal baclofen therapy
Albright, A. L., Turner, M. S., & Pattisapu, J. V. (2006) · Journal of Neurosurgery Pediatrics · doi:10.3171/ped.2006.104.4.233 · Cited by 149
Harvey, A., Kaestner, S. A., Sutter, D. E., Harvey, N. G., Mikszta, J. A., & Pettis, R. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0123-9 · Cited by 148
Wilkinson, G. R. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00040-9 · Cited by 145
Controlled Release Systems Containing Solid Dispersions: Strategies and Mechanisms
Tran, P. H. L., Tran, T. T. D., Park, J.-B., & Lee, B. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0449-y · Cited by 140
Kim, M. T., Sedykh, A., Chakravarti, S., Saiakhov, R., & Zhu, H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1222-1 · Cited by 140
Horisawa, E., Hirota, T., Kawazoe, S., Yamada, J., Yamamoto, H., Takeuchi, H., & Kawashimà, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1015123024113 · Cited by 138
Contraception by means of a Silastic vaginal ring impregnated with medroxyprogesterone acetate
Mishell, D. R., Tálas, M., Parlow, A. F., et al. (1970) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33897-2 · Cited by 138
Shamloo, A., Sarmadi, M., Aghababaie, Z., & Vossoughi, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.045 · Cited by 137
Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres
Ravivarapu, H. B. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00099-0 · Cited by 134
Ong, B. Y. S., Ranganath, S. H., Lee, L. Y., Fan, L., Lee, H. S., Sahinidis, N. V., & Wang, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.030 · Cited by 132
In vivo release from a drug delivery MEMS device
李雅文, Shawgo, R. S., Tyler, B., Henderson, P. T., Vogel, J. S., Rosenberg, A., Storm, P. B., Langer, R., Brem, H., & Cima, M. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.018 · Cited by 131
An implantable MEMS drug delivery device for rapid delivery in ambulatory emergency care
Elman, N. M., Duc, H. L. H., & Cima, M. J. (2009) · Biomedical Microdevices · doi:10.1007/s10544-008-9272-6 · Cited by 116
Ranganath, S. H., Kee, I. H. C., Krantz, W. B., Chow, P. K. H., & Wang, C.-H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9922-2 · Cited by 113
Protein‐Release Behavior of Self‐Assembled PEG–β‐Cyclodextrin/PEG–Cholesterol Hydrogels
van de Manakker, F., Braeckmans, K., el Morabit, N., Smedt, S. C. D., van Nostrum, C. F., & Hennink, W. E. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200900603 · Cited by 112
Busatto, C. A., Pesoa, J., Helbling, I. M., Luna, J. A., & Estenoz, D. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.006 · Cited by 109
Kim, Y.-Y., Lee, J.-S., Kang, H.-J., & Park, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-30740-y · Cited by 108
Park, E., Maniar, M. L., & Shah, J. C. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00223-x · Cited by 107
Implantable intrathecal pumps for chronic pain: highlights and updates.
Knight, K. H., Brand, F., Mchaourab, A. S., & Veneziano, G. (2007) · PubMed · Cited by 103
A study of drug release from homogeneous PLGA microstructures
Acharya, G. S., Shin, C. S., Vedantham, K., McDermott, M. D., Rish, T., Hansen, K. S., Fu, Y., & Park, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.024 · Cited by 103
Pessi, J., Santos, H. A., Miroshnyk, I., JoukoYliruusi, Weitz, D. A., & Mirza, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.06.012 · Cited by 101
Development and evaluation of osmotically controlled oral drug delivery system of glipizide
Verma, R. K., & Garg, S. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.02.003 · Cited by 98
In vivo delivery of BCNU from a MEMS device to a tumor model
李雅文, Duc, H. L. H., Tyler, B., Williams, T., Tupper, M. M., Langer, R., Brem, H., & Cima, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.009 · Cited by 96
Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model
Kim, G., Tyler, B., Tupper, M. M., Karp, J. M., Langer, R., Brem, H., & Cima, M. J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.003 · Cited by 94
Yan, H., Casalini, T., Hulsart‐Billström, G., Wang, S., Oommen, O. P., Salvalaglio, M., Larsson, S., Hilborn, J. G., & Varghese, O. P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.041 · Cited by 94
Hanes, J. S., Chiba, M., & Langer, R. (1998) · Biomaterials · doi:10.1016/s0142-9612(97)00221-4 · Cited by 92
Herrmann, J., & Bodmeier, R. A. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00051-9 · Cited by 92
Schlesinger, E. B., Johengen, D., Luecke, E. H., Rothrock, G. D., McGowan, I., van der Straten, A., & Desai, T. A. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1904-6 · Cited by 92
Chai, X., Li, D., Cao, X., Zhang, Y., Mu, J., Lu, W., Xiao, X., Li, C., Meng, J., Chen, J., et al. (2017) · Scientific Reports · doi:10.1038/srep41900 · Cited by 89
Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNU
Dang, W., Daviau, T., Ying, P., Zhao, Y., Nowotnik, D. P., Clow, C. S., Tyler, B., & Brem, H. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01371-5 · Cited by 88
A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
Zhao, Y., Xu, X., Wen, N., Song, R., Meng, Q., Guan, Y., Cheng, S., Cao, D., Dong, Y., Qie, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05898-6 · Cited by 82
Therapeutic drug monitoring of cancer chemotherapy
Alnaim, L. S. (2007) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155207081133 · Cited by 80
Mathematical model accurately predicts protein release from an affinity-based delivery system
Vulic, K., Pakulska, M. M., Sonthalia, R., Ramachandran, A., & Shoichet, M. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.032 · Cited by 79
Patil, S. B., Inamdar, S. Z., Das, K. K., Akamanchi, K. G., Patil, A. V., Inamadar, A. C., Reddy, K. R., Raghu, A. V., & Kulkarni, R. V. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101525 · Cited by 79
Masters, D. B., Berde, C. B., Dutta, S., Turek, T., & Langer, R. (1993) · Pharmaceutical Research · doi:10.1023/a:1018995913972 · Cited by 78
Anderson, E. M., Noble, M. L., Garty, S., Ma, H., Bryers, J. D., Shen, T. T., & Ratner, B. D. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.047 · Cited by 78
Patil, S. B., Inamdar, S. Z., Reddy, K. R., Raghu, A. V., Soni, S. K., & Kulkarni, R. V. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.03.009 · Cited by 75
Tae, G., Kornfield, J. A., & Hubbell, J. A. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.01.042 · Cited by 73
Landgren, B.-M., JOHANNISSON, E., Masironi, B., et al. (1982) · Contraception · doi:10.1016/0010-7824(82)90132-9 · Cited by 72
Su, Z., Sun, F., Shi, Y., Jiang, C., Meng, Q., Teng, L., & Li, Y. (2009) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.57.1251 · Cited by 67
Design of triptorelin loaded nanospheres for transdermal iontophoretic administration
Nicoli, S., Santi, P., Couvreur, P., Couarraze, G., Colombo, P., & Fattal, E. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00632-3 · Cited by 67
Microchips and controlled‐release drug reservoirs
Staples, M. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.93 · Cited by 66
Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model
Masi, B. C., Tyler, B., Bow, H. C., Wicks, R. T., Xue, Y., Brem, H., Langer, R., & Cima, M. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.048 · Cited by 64
In vitro and in vivo demonstration of risperidone implants in mice
Rabin, C., Liang, Y., Ehrlichman, R. S., Budhian, A., Metzger, K. L., Majewski-Tiedeken, C., Winey, K. I., & Siegel, S. J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.08.003 · Cited by 64
Tobias, I. S., Lee, H., Engelmayr, G. C., Macaya, D. J., Bettinger, C. J., & Cima, M. J. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.036 · Cited by 61
Understanding and utilizing the biomolecule/nanosystems interface
Chen, E. Y., Liu, W. F., Megido, L., Díez, P., Fuentes, M., Fager, C., Olsson, E., Gessner, I., & Mathur, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48063-5.00003-4 · Cited by 60
Transdermal Insulin Delivery Using Microdermabrasion
Andrews, S., Lee, J. W., Choi, S., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0435-4 · Cited by 58
Development of Risperidone PLGA Microspheres
D’Souza, S. S., Faraj, J. A., Giovagnoli, S., & DeLuca, P. P. (2014) · Journal of Drug Delivery · doi:10.1155/2014/620464 · Cited by 57
Alternative routes of administration for systemic delivery of protein pharmaceuticals
Moeller, E. H., & Jørgensen, L. (2008) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2008.11.005 · Cited by 57
Ozeki, T., Kaneko, D., Hashizawa, K., Imai, Y., Tagami, T., & Okada, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.02.012 · Cited by 55
New delivery systems in contraception: vaginal rings
Johansson, E. D. B., & Sitruk-Ware, R. L. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.056 · Cited by 54
A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment
Verma, M., Vishwanath, K., Eweje, F. R., Roxhed, N., Grant, T. M., Castaneda, M., Steiger, C., Mazdiyasni, H., Bensel, T., Minahan, D. J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6267 · Cited by 53
Wu, X. S. (2004) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.1081/bio-200039635 · Cited by 51
Ravivarapu, H. B., Lee, H., & DeLuca, P. P. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100100543 · Cited by 51
Sung, K. C., Han, R.-Y., Hu, O. Y., & Hsu, L.-R. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00156-2 · Cited by 50
Villanueva, J. R., Bravo‐Osuna, I., Herrero‐Vanrell, R., Molina-Martínez, I. T., & Guzmán, M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.03.012 · Cited by 49
A once-a-month oral contraceptive
Kirtane, A. R., Hua, T., Hayward, A. M., Bajpayee, A. G., Wahane, A. V., Lopes, A., Bensel, T., Ma, L., Stanczyk, F. Z., Brooks, S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aay2602 · Cited by 49
The Biodegradation of Biodegradable Polymeric Biomaterials
Lin, C., & Anseth, K. S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-08-087780-8.00061-9 · Cited by 48
Wang, G., Tucker, I. G., Roberts, M. S., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016062825360 · Cited by 48
Cai, C., Mao, S., Germershaus, O., Schaper, A., Rytting, E., Chen, D., & Kissel, T. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802354707 · Cited by 48
Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES
McBride, J. W., Boyd, P., Dias, N., Cameron, D., Offord, R. E., Hartley, O., Kett, V. L., & Malcolm, K. R. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.003 · Cited by 48
Sharma, S., Nijdam, A. J., Sinha, P. M., Walczak, R. J., Liu, X., Cheng, M. M., & Mauro Ferrari, B. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.379 · Cited by 47
Wu, C., Zhao, Z., Zhao, Y., Hao, Y., Liu, Y., & Liu, C. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.033 · Cited by 45
Effect of geometry on the erosion characteristics of polyanhydride matrices
Javar, H. A., D’Emanuele, A., & Attwood, D. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00298-6 · Cited by 45
Hanes, J. S., Chiba, M., & Langer, R. (1996) · Macromolecules · doi:10.1021/ma960393f · Cited by 44
Drug release from a new family of biodegradable polyanhydrides
Shieh, L. Y., Tamada, J. A., Tabata, Y., Domb, A. J., & Langer, R. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90123-6 · Cited by 43
Nanochannel Technology for Constant Delivery of Chemotherapeutics: Beyond Metronomic Administration
Grattoni, A., Shen, H., Fine, D., Žiemys, A., Gill, J. S., Lee, H., Hosali, S., Goodall, R., Liu, X., & Mauro Ferrari, B. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0195-6 · Cited by 43
Functionalization of nanoparticles in specific targeting and mechanism release
Adamo, G., Campora, S., & Ghersi, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46142-9.00003-7 · Cited by 43
Ho, R. J. Y., & Gibaldi, M. (2013) · Wiley eBooks · doi:10.1002/9781118660485.ch16 · Cited by 42
Su, Z., Shi, Y., Teng, L., Li, X., Wang, L.-X., Meng, Q., Teng, L., & Li, Y. (2010) · Pharmaceutical Development and Technology · doi:10.3109/10837451003739297 · Cited by 42
Manoharan, C., & Singh, J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21741 · Cited by 42
Patel, M. R., Patel, R. B., & Thakore, S. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813741-3.00030-3 · Cited by 40
Algorta, J., Diaz, M., de Benito, R., Lefebvre, M., Sicard, É., Furtado, M., Regidor, P., & Ronchi, C. (2017) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2017.1413179 · Cited by 39
Introductory Chapter: Drug Delivery Concepts
Maiti, S., & Sen, K. K. (2017) · InTech eBooks · doi:10.5772/65245 · Cited by 38
Clinical Accuracy and Safety Using the SynchroMed II Intrathecal Drug Infusion Pump
Wesemann, K., Coffey, R. J., Wallace, M. S., Tan, Y., Broste, S. K., & Buvanendran, A. (2014) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000107 · Cited by 37
Weisberg, E., Fraser, I. S., Mishell, D. R., Lacarra, M., Darney, P., & Jackanicz, T. M. (1999) · Contraception · doi:10.1016/s0010-7824(99)00036-0 · Cited by 37
PLGA microparticles with zero-order release of the labile anti-Parkinson drug apomorphine
Regnier-Delplace, C., Boullay, O. T. D., Siepmann, F., Martín-Vaca, B. M., Degrave, N., Demonchaux, P., Jentzer, O., Bourissou, D., & Siepmann, J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.008 · Cited by 36
Dynamic Model of Biomolecular Diffusion through Two-Dimensional Nanochannels
Cosentino, C., Amato, F., Walczak, R. J., Boiarski, A. A., & Mauro Ferrari, B. (2005) · The Journal of Physical Chemistry B · doi:10.1021/jp045478u · Cited by 35
Luaces-Rodríguez, A., Díaz-Tomé, V., González‐Barcia, M., Silva‐Rodríguez, J., Herranz, M., Gil‐Martínez, M., Ares, M. T. R., García-Mazás, C., Blanco-Méndez, J., Lamas, M. J., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.060 · Cited by 35
Xu, W.-J., Li, N., & Gao, C. (2011) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2011.04.002 · Cited by 31
The Unhidden Cost of Noncompliance
Mahoney, J. J., Ansell, B. J., Fleming, W. K., & Butterworth, S. W. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.s6-b.1 · Cited by 31
Cited by
Drug release study of the chitosan-based nanoparticles
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · Heliyon · doi:10.1016/j.heliyon.2021.e08674 · Cited by 576
“However, excessive release can reduce the therapeutic efficacy, resulting in delayed drug delivery [28].”
BackgroundOvercoming barriers to patient adherence: the case for developing innovative drug delivery systems
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 492
Self-citationKinetic Modeling to Explain the Release of Medicine from Drug Delivery Systems
Askarizadeh, M., Esfandiari, N., Honarvar, B., Sajadian, S. A., & Azdarpour, A. (2023) · ChemBioEng Reviews · doi:10.1002/cben.202300027 · Cited by 318
Designing spatial and temporal control of vaccine responses
Roth, G. A., Picece, V. C. T. M., Ou, B. S., Luo, W., Pulendran, B., & Appel, E. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00372-2 · Cited by 316
Recent Applications of PLGA in Drug Delivery Systems
Yang, J., Zeng, H., Luo, Y., Chen, Y., Wang, M., Wu, C., & Hu, P. (2024) · Polymers · doi:10.3390/polym16182606 · Cited by 268
Metadata
- Authors
- Laracuente, M.-L., Yu, M. H., & McHugh, K. J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 327
- Pages
- 834-856
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W3086057753
- Cited by
- 384
- References
- 219
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.